GPC3 and breast cancer: For instance in hepatocellular carcinoma (HCC), an overexpression of glypican-3 increases the migratory ability and invasive capacity of cancer cells by reducing cell adhesion to fibronectin (Kwack et al. 2006) whereas it plays an inhibitory role in breast cancer.